Background While barriers to accessing buprenorphine (BUP) therapy have been well
described, little is known about pharmacy-related barriers. The objective of this study was to …

Abstract Background and Aims Buprenorphine is commonly used to treat opioid use
disorder; however, non‐buprenorphine prescription opioid use among these patients is not …

Background Increasing buprenorphine prescribing for opioid use disorder (OUD) has been
a major focus of US opioid response efforts. However, concerns related to dispensing …

Importance There is a lack of empirical research regarding misuse of buprenorphine
hydrochloride. Objective To identify prescription opioids that are most frequently misused …

Background & objective Buprenorphine is an underutilized pharmacotherapy that can play a
key role in combating the opioid epidemic. Individuals with opioid use disorder (OUD) often …

Objective The purpose of the present study was to examine the motivations underlying the
use of buprenorphine outside of therapeutic channels and the factors that might account for …

Background Buprenorphine is approved in many countries for the treatment of opioid use
disorder (OUD), but problems with diversion and abuse exist. There is a need to understand …

Background Attention-deficit and hyperactivity disorder (ADHD) is frequently diagnosed in
patients with substance use disorders (SUDs), including opioids. There remains concern …

Importance Stimulant medication use is common among individuals receiving
buprenorphine for opioid use disorder (OUD). Associations between prescription stimulant …

Abstract Background and Aims Expanding access to medication‐assisted treatment with
buprenorphine is a cornerstone of the opioid crisis response, yet buprenorphine remains …